Bioventus makes pain treatment and surgical products for musculoskeletal care, sold to physicians, surgeons and hospitals. It last closed at $10.60 on Nov 17, up 1.34% on the day. In the past 30 days there were 1 dark pool print totaling $276K, the largest $276K.
Only 1 firm rated BVS in the past 90 days, not enough for a consensus
Average 12-month target
$18.00
▲ 69.8% upside
Based on 1 analyst who set a price target on BVS in the past 90 days. The average target is $18.00, with a high of $18.00 and a low of $18.00, compared with the last close of $10.60.
Low $18.00Avg $18.00High $18.00
Blue marker: last close $10.60
Highest target$18.00
Average target$18.00
Lowest target$18.00
Latest rating changes
Canaccord GenuityTarget lowered
Nov 3Buy$19 → $18
Canaccord GenuityTarget raised
Aug 17Buy$15 → $19
Cantor FitzgeraldReiterated
Aug 17Buy$15
Barrington ResearchMaintained
Jun 30Buy$14
Canaccord GenuityMaintained
Jun 16Buy$15
Date
Firm
Action
Rating
Price target
Nov 3
Canaccord Genuity
Target lowered
Buy
$19 → $18
Aug 17
Canaccord Genuity
Target raised
Buy
$15 → $19
Aug 17
Cantor Fitzgerald
Reiterated
Buy
$15
Jun 30
Barrington Research
Maintained
Buy
$14
Jun 16
Canaccord Genuity
Maintained
Buy
$15
Loading…
Technical Analysis
BVS · as of the Nov 17 close · updated after every close
Pullback inside a longer uptrend, nearing oversold
The stock is 17% below its 20 day and 23% below its 50 day average. It is 5% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 33), near oversold. The nearest support is the Pivot at $10.48, and the nearest resistance the Pivot R1 at $10.75.
Short trendBearish
Long trendBullish
MomentumWeak
StretchNear oversold
VolatilityHigh, 5.9%/day
Key levels
$15.8952 week high+49.9%
$13.0050 day average+22.6%
$12.98100 day average+22.5%
$12.4420 day average+17.4%
$11.09200 day average+4.6%
$11.00Swing high (May 20)+3.8%
$10.75Pivot R1+1.4%
$10.60Last close
$10.48Pivot−1.1%
$10.32Pivot S1−2.6%
$10.09Swing low (Nov 3)−4.8%
$6.4752 week low−39.0%
Indicators
RSI (14)
33.50
Weak, oversold below 30
Neutral
MACD
-0.84
Below its signal line
Bearish
Stochastic
9.7
Near the bottom of its range
Oversold
ADX (14)
30.1
Trending down
Williams %R
-89.8
Oversold below −80, overbought above −20
Oversold
CCI (20)
-75.5
Oversold below −100, overbought above 100
Neutral
Rate of change
−3.1%
Change over 10 sessions
Bearish
ATR (14)
$0.62
Typical daily range, 5.9% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Pullback inside a longer uptrend
Short trendBearish
Long trendBullish
MomentumWeak
StretchNormal
VolatilityNormal, 12.5%/day
Key levels
$15.8952 week high+49.9%
$13.0050 day average+22.6%
$12.98100 day average+22.5%
$12.4420 day average+17.4%
$11.09200 day average+4.6%
$11.00Swing high (May 20)+3.8%
$10.75Pivot R1+1.4%
$10.60Last close
$10.48Pivot−1.1%
$10.32Pivot S1−2.6%
$10.09Swing low (Nov 3)−4.8%
$6.4752 week low−39.0%
Indicators
RSI (14)
42.90
Middle of its range
Neutral
MACD
0.33
Below its signal line
Bearish
Stochastic
9.9
Near the bottom of its range
Oversold
ADX (14)
39.9
Trending up
Williams %R
-90.3
Oversold below −80, overbought above −20
Oversold
CCI (20)
-165.1
Oversold below −100, overbought above 100
Oversold
Rate of change
−18.3%
Change over 10 sessions
Bearish
ATR (14)
$1.32
Typical daily range, 12.5% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200Above
What happened before, for BVS
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how BVS did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow BVS usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How BVS has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2021.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether BVS is in one of them and how their past BVS trades turned out.
Bioventus is a medical device company based in Durham, North Carolina. It makes products that relieve pain and treat musculoskeletal conditions, including hyaluronic acid knee injections, implantable nerve stimulation systems for chronic pain, and ultrasonic bone cutting tools used in spine and neurosurgery. The company also offers bone graft substitutes that support bone fusion and a device that uses low intensity pulse ultrasound to help fractures heal. Its customers include physicians and surgeons, along with the hospitals, clinics and ambulatory surgical centers where patients are treated.